LYON, France, June 2, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the Ministry of Health in Argentina has approved Ablatherm-HIFU (high-intensity focused ultrasound) as a minimally invasive treatment option for patients with localized prostate cancer. Argentina closely follows Brazil as the latest country in South America to approve the device.
